178 related articles for article (PubMed ID: 10692565)
21. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
Merchant M; Krishnan V; Safe S
Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
[TBL] [Abstract][Full Text] [Related]
23. Activation of mitogen-activated protein kinases (MAPKs) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (AHR) function.
Tan Z; Chang X; Puga A; Xia Y
Biochem Pharmacol; 2002 Sep; 64(5-6):771-80. PubMed ID: 12213569
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.
Ciolino HP; Daschner PJ; Yeh GC
Cancer Res; 1998 Dec; 58(24):5707-12. PubMed ID: 9865727
[TBL] [Abstract][Full Text] [Related]
25. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
Ciolino HP; Daschner PJ; Yeh GC
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line.
Harper PA; Golas CL; Okey AB
Cancer Res; 1988 May; 48(9):2388-95. PubMed ID: 2833345
[TBL] [Abstract][Full Text] [Related]
27. Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme.
Yao Y; Hoffer A; Chang CY; Puga A
Environ Health Perspect; 1995 Apr; 103(4):366-71. PubMed ID: 7607137
[TBL] [Abstract][Full Text] [Related]
28. Superinduction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome.
Joiakim A; Mathieu PA; Elliott AA; Reiners JJ
Mol Pharmacol; 2004 Oct; 66(4):936-47. PubMed ID: 15385644
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the regulatory domains of the murine Cyp1a1 gene with two DNA-binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT).
Carrier F; Chang CY; Duh JL; Nebert DW; Puga A
Biochem Pharmacol; 1994 Nov; 48(9):1767-78. PubMed ID: 7980646
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wang WL; Porter W; Burghardt R; Safe SH
Carcinogenesis; 1997 May; 18(5):925-33. PubMed ID: 9163677
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand.
Crawford RB; Holsapple MP; Kaminski NE
Mol Pharmacol; 1997 Dec; 52(6):921-7. PubMed ID: 9415701
[TBL] [Abstract][Full Text] [Related]
32. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action.
Probst MR; Reisz-Porszasz S; Agbunag RV; Ong MS; Hankinson O
Mol Pharmacol; 1993 Sep; 44(3):511-8. PubMed ID: 8396713
[TBL] [Abstract][Full Text] [Related]
33. Suppressive effects of alpha-Hederin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated murine Cyp1a-1 expression in the mouse hepatoma Hepa-1c1c7 cells.
Jeong HG; Lee SS
Cancer Lett; 1999 Apr; 138(1-2):131-7. PubMed ID: 10378784
[TBL] [Abstract][Full Text] [Related]
34. Comparative effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on MCF-7, RL95-2, and LNCaP cells: role of target steroid hormones in cellular responsiveness to CYP1A1 induction.
Jana NR; Sarkar S; Ishizuka M; Yonemoto J; Tohyama C; Sone H
Mol Cell Biol Res Commun; 2000 Sep; 4(3):174-80. PubMed ID: 11281733
[TBL] [Abstract][Full Text] [Related]
35. Cell-type specificity of ectonucleotidase expression and upregulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wood E; Broekman MJ; Kirley TL; Diani-Moore S; Tickner M; Drosopoulos JH; Islam N; Park JI; Marcus AJ; Rifkind AB
Arch Biochem Biophys; 2002 Nov; 407(1):49-62. PubMed ID: 12392715
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
37. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
38. 2,3,7,8-Tetrachlorodibenzo-p-dioxin's suppression of 1-nitropyrene-induced p53 expression is mediated by cytochrome P450 1A1.
Su JG; Huang MC; Chen FY
Chem Res Toxicol; 2011 Dec; 24(12):2167-75. PubMed ID: 22044530
[TBL] [Abstract][Full Text] [Related]
39. Ah receptor mediating induction of cytochrome P450IA1 in a novel continuous human liver cell line (Mz-Hep-1). Detection by binding with [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin and relationship to the activity of aryl hydrocarbon hydroxylase.
Roberts EA; Johnson KC; Dippold WG
Biochem Pharmacol; 1991 Jul; 42(3):521-8. PubMed ID: 1650214
[TBL] [Abstract][Full Text] [Related]
40. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic stellate cell (HSC) activation and liver fibrosis in C57BL6 mouse via activating Akt and NF-κB signaling pathways.
Han M; Liu X; Liu S; Su G; Fan X; Chen J; Yuan Q; Xu G
Toxicol Lett; 2017 May; 273():10-19. PubMed ID: 28302560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
